Business Context and Reporting Period
This Form 6-K filing by Agroz Inc. (a Foreign Private Issuer) covers the month of January 2026, with the report signed on April 16, 2026. The filing discloses a material agreement entered into by Agroz Group Sdn. Bhd., the Company's operating subsidiary, to develop a comprehensive Robotics AI platform.
Key Financial Metrics and Transaction Details
The filing details a specific contractual obligation rather than standard periodic financial results. Key metrics include:
- Total Contract Value: $10,000,000 for the design, development, and implementation of the Robotics AI platform.
- Payment Structure: Payments are milestone-based (10% mobilization, 20% Phase 1, 30% Phase 2, 20% User Acceptance Testing, 20% Final Delivery).
- Equity Settlement: The $2,000,000 consideration for Milestone #2 (Phase 1 completion) is to be paid via the issuance of 4,000,000 Ordinary Shares of the Company.
- Share Par Value: $0.0001 per share.
The filing text does not provide clear values for revenue, profit, cash flow, margins, total debt, or liquidity positions for the reporting period.
Material Changes and Unusual Items
The primary material change is the execution of the Robotic Development Agreement with Braiven Sdn Bhd on January 2, 2026. A significant unusual item is the agreement reached on March 25, 2026, to settle the $2,000,000 Milestone #2 payment obligation through equity issuance rather than cash. The Developer has assigned the right to receive these Consideration Shares to various individuals.
Guidance, Outlook, and Risks
Outlook: The Company intends to utilize the new platform to empower users to build custom robotic applications across various industries.
Risks and Contingencies:
- Termination Risk: The agreement may be terminated by either party upon 45 days' written notice if the other party breaches material responsibilities and fails to rectify the breach.
- Dilution Risk: The issuance of 4,000,000 shares to settle a milestone payment represents a potential dilution event for existing shareholders.
- Execution Risk: The project is subject to phased development and User Acceptance Testing, with future payments contingent on these milestones.
Investor Verification Checklist
- Verify the exact number of shares outstanding post-issuance to assess the dilution impact of the 4,000,000 Consideration Shares.
- Review the full text of the Robotic Development Agreement (Exhibit 10.1) for specific technical milestones and redacted terms.
- Confirm the identity of the "various individuals" to whom the Developer assigned the share entitlements.
- Monitor future filings for cash flow impacts related to the remaining $8,000,000 of the contract value.